Vitamin D enhances placental innate immunity
Oncothyreon Inc. announced today that Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax and, through its affiliate EMD Serono Canada Inc., purchased current inventory and certain assets utilized for the manufacture of Stimuvax from Oncothyreon for consideration which includes net payments to Oncothyreon totaling approximately U.S. $13 million. Merck KGaA currently
Full Post: Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon
In a paper available at the online site of the journal Biology of Reproduction, a team of UCLA researchers reports for the first time that vitamin D induces immune responses in placental tissues by stimulating production of the antimicrobial protein cathelicidin.
The study involved exposing cultured human trophoblast cells to the active form of vitamin D, leading to production of cathelicidin and an increased antibacterial response in the trophoblast cells.
The team, headed by Dr. Martin Hewison, suspects that the ability of the placenta to synthesize cathelicidin varies widely among women. Their discovery suggests that placental innate immunity can be enhanced if pregnant women supplement their diets with vitamin D.
Induction of cathelicidin production by vitamin D may help the placenta stave off infection by a variety of pathogenic organisms, including staphylococcus, streptococcus, and E. coli bacteria. Vitamin D may also enhance and sustain this bacterial killing by protecting placental trophoblast cells from infection-associated cell death.
The significance of vitamin D in human reproduction has been recognized for the past 20 years, although its exact role has not been completely understood. This study presents a new mechanism for activation of innate immune responses in the placenta to protect it from infectious bacteria and sheds new light on the possible role of vitamin D in pregnancy and pregnancy-associated infection.
The immune system’s battle against invading bacteria reaches its peak activity at night and is lowest during the day. Experiments with the laboratory model organism, Drosophila melanogaster, reveal that the specific immune response known as phagocytosis oscillates with the body’s circadian rhythm, according to Stanford researchers who presented their findings at the American Society for
Full Post: Research suggests that immunity is stronger at night
University of Rochester Medical Center scientists discovered a gene mutation that impairs the placenta and also is influential in cancer development, according to a study published online December 16, 2008, in the journal PLoS (Public Library of Science) Biology. The investigation is the first to link the key placental gene, SENP2, to the well-known p53
Full Post: Study of placenta unexpectedly leads to cancer gene
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria. The findings may let doctors detect earlier two crippling malaria variations - one that develops in the placenta of pregnant women affecting countless unborn children, the other, cerebral malaria, that develops in the brain’s
Full Post: Biomarkers in blood could aid diagnosis of two severe and debilitating forms of malaria
Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60%. It is not currently understood to what degree physical activity during pregnancy protects against pre-eclampsia, compared to previous studies. This is shown in two new studies from the Norwegian Institute of Public Health (NIPH) that use data from
Full Post: Reduced risk for pre-eclampsia among women who have aborted
Exposure to folic acid antagonists during pregnancy is associated with a higher risk of placenta-mediated adverse outcomes such as preeclampsia, placental abruption, fetal growth restriction or fetal death reports a retrospective cohort study published in CMAJ (pdf). Folic acid antagonists include a broad range of drugs used to treat epilepsy, mood disorders, hypertension and infections.
Full Post: Exposure to folic acid antagonists during pregnancy has risks